What amount sold does Verdad Japan Fund, L.P. report in Form D filings?

The latest linked filings report $86.4M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Verdad Japan Fund, L.P.'s most recent SEC filing?

Verdad Japan Fund, L.P.'s most recent Form D filing was on 2026-07-09.

How many investors does Verdad Japan Fund, L.P. have?

The most recent Form D filing lists 119 investor(s).

Verdad Japan Fund, L.P.

CIK: 0001702895·Pooled Investment Fund·BOSTON, MA·Limited Partnership

Reported Sold

$86,433,228

Total Filings

Identified Offerings

Last Filed

Jul 9, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Jul 9, 2026Form D/A — Amendment

Reported sold: $86,433,228 · Target: Indefinite

Rule 506(b)·119 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 11, 2025Form D/A — Amendment

Reported sold: $82,283,228 · Target: Indefinite

Rule 506(b)·115 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 14, 2023Form D/A — Amendment

Reported sold: $56,633,253 · Target: Indefinite

Rule 506(b)·109 investors·Section 3(c), Section 3(c)(1)

Changed: Reported investors

Jul 15, 2022Form D/A — Amendment

Reported sold: $56,633,253 · Target: Indefinite

Rule 506(b)·99 investors·Section 3(c), Section 3(c)(1)

Changed: Reported investors

Jul 16, 2021Form D/A — Amendment

Reported sold: $56,633,253 · Target: Indefinite

Rule 506(b)·89 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 16, 2020Form D/A — Amendment

Reported sold: $56,633,253 · Target: Indefinite

Rule 506(b)·96 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 16, 2019Form D/A — Amendment

Reported sold: $52,303,253 · Target: Indefinite

Rule 506(b)·89 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 17, 2018Form D/A — Amendment

Reported sold: $39,114,653 · Target: Indefinite

Rule 506(b)·62 investors·Section 3(c), Section 3(c)(1)

May 24, 2018Form D/A — Amendment

Reported sold: $39,114,653 · Target: Indefinite

Rule 506(b)·62 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jun 5, 2017Form D — New notice

Reported sold: $8,920,000 · Target: Indefinite

Rule 506(b)·18 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

119

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

90%

Latest reported sold across 1 identified offering

$86,433,228

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

VLCF GP, L.P.

Related Person

Appears on 7 filings

VERDAD ASSET MANAGEMENT, LLC

Related Person

Appears on 7 filings

Daniel Rasmussen

Related Person

Appears on 7 filings

Verdad Asset Management, LLC

Related Person

Appears on 2 filings

VLCF GP, L.P.

Related Person

Appears on 2 filings

Daniel Rasmussen

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 9, 2026	Amendment	Indefinite	$86,433,228	119
Jul 11, 2025	Amendment	Indefinite	$82,283,228	115
Jul 14, 2023	Amendment	Indefinite	$56,633,253	109
Jul 15, 2022	Amendment	Indefinite	$56,633,253	99
Jul 16, 2021	Amendment	Indefinite	$56,633,253	89
Jul 16, 2020	Amendment	Indefinite	$56,633,253	96
Jul 16, 2019	Amendment	Indefinite	$52,303,253	89
Jul 17, 2018	Amendment	Indefinite	$39,114,653	62
May 24, 2018	Amendment	Indefinite	$39,114,653	62
Jun 5, 2017	New	Indefinite	$8,920,000	18

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026